Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2958021000168117 | Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2958031000168119 | Irinotecan Hydrochloride Trihydrate (Mayne Pharma) (irinotecan hydrochloride trihydrate 40 mg / 2 mL) injection, 2 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | Is a | Irinotecan Hydrochloride Trihydrate (Mayne Pharma) | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | Is a | irinotecan hydrochloride trihydrate 40 mg/2 mL injection, vial | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | has manufactured dose form | concentrated injection | false | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1542393790 | |
| Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | has Australian BoSS | irinotecan hydrochloride trihydrate | true | Inferred relationship | Some | 1542393789 | |
| Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | has intended active ingredient | irinotecan | true | Inferred relationship | Some | 1542393789 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | has TPUU | True | Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | Inferred relationship | Some | 1 |
| Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | has TPUU | True | Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Trade product unit of use reference set
FHIR